The roles of the A- and B-chains of human relaxin-2 and -3 on their biological activity

Current Protein and Peptide Science

Volumn 11, Issue 8, 2010, Pages 719-724

  Hossain, Mohammed Akhter ^a   Wade, John D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

H2 relaxin; H3 relaxin; INSL3; Relaxin; RXFP1; RXFP3

Indexed keywords

RELAXIN; RELAXIN 2; RELAXIN 3; UNCLASSIFIED DRUG;

ALPHA CHAIN; ARTICLE; BETA CHAIN; BINDING AFFINITY; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79951731907     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310794557736     Document Type: Article

References (29)

1. Bathgate, R.A.; Ivell, R.; Sanborn, B.M.; Sherwood, O.D.; Summers, R.J. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev., 2006, 58, 7-31.
2. Hsu, S.Y.; Nakabayashi, K.; Nishi, S.; Kumagai, J.; Kudo, M.; Sherwood, O.D.; Hsueh, A.J. Activation of orphan receptors by the hormone relaxin. Science, 2002, 295, 671-674.
3. Kumagai, J.; Hsu, S.Y.; Matsumi, H.; Roh, J.S.; Fu, P.; Wade, J.D.; Bathgate, R.A.; Hsueh, A J. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem., 2002, 277, 31283-31286.
4. Liu, C.; Eriste, E.; Sutton, S.; Chen, J.; Roland, B.; Kuei, C.; Farmer, N.; Jornvall, H.; Sillard, R.; Lovenberg, T.W. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan Gprotein- coupled receptor GPCR135. J. Biol. Chem., 2003, 278, 50754-50764.
5. Liu, C.; Chen, J.; Sutton, S.; Roland, B.; Kuei, C.; Farmer, N.; Sillard, R.; Lovenberg, T.W. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J. Biol. Chem., 2003, 278, 50765-50770.
6. Liu, C.; Kuei, C.; Sutton, S.; Chen, J.; Bonaventure, P.; Wu, J.; Nepomuceno, D.; Kamme, F.; Tran, D.T.; Zhu, J.; Wilkinson, T.; Bathgate, R.; Eriste, E.; Sillard, R.; Lovenberg, T.W. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J. Biol. Chem., 2005, 280, 292-300.
7. Hossain, M.A.; Rosengren, K.J.; Haugaard-Jonsson, L.M.; Zhang, S.; Layfield, S.; Ferraro, T.; Daly, N.L.; Tregear, G.W.; Wade, J.D.; Bathgate, R.A. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. J. Biol. Chem., 2008, 283, 17287-17297.
8. Baccari, M.C.; Calamai, F. Relaxin: new functions for an old peptide. Curr. Protein Pept. Sci, 2004, 5, 9-18.
9. Teichman, S.L.; Unemori, E.; Teerlink, J.R.; Cotter, G.; Metra, M. Relaxin: review of biology and potential role in treating heart failure. Curr. Heart Fail. Rep., 2010, 7, 75-82.
10. Teerlink, J.R.; Metra, M.; Felker, G.M.; Ponikowski, P.; Voors, A.A.; Weatherley, B.D.; Marmor, A.; Katz, A.; Grzybowski, J.; Unemori, E.; Teichman, S.L.; Cotter, G. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet, 2009, 373, 1429-1439.
11. Büllesbach, E.E.; Schwabe, C. On the receptor binding site of relaxins. Int. J. Pept. Protein Res., 1988, 32, 361-367.
12. Büllesbach, E.E.; Schwabe, C. Total synthesis of human relaxin and human relaxin derivatives by solid-phase peptide synthesis and site-directed chain combination. J. Biol. Chem., 1991, 266, 10754-10761.
13. Büllesbach, E.E.; Yang, S.; Schwabe, C. The receptor-binding site of human relaxin II. A dual prong-binding mechanism. J. Biol. Chem., 1992, 267, 22957-22960.
14. Büllesbach, E.E.; Schwabe, C. The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. J. Biol. Chem., 2000, 275, 35276-35280.
15. Büllesbach, E.E.; Schwabe, C. The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7. J. Biol. Chem., 2005, 280, 14051-14056.
16. Büllesbach, E.E.; Schwabe, C. Preparation and properties of porcine relaxin derivatives shortened at the amino terminus of the A chain. Biochemistry, 1986, 25, 5998-6004.
17. Büllesbach, E.E.; Schwabe, C. Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix. J. Biol. Chem., 1987, 262, 12496-12501.
18. Büllesbach, E.E.; Schwabe, C. LGR8 signal activation by the relaxin- like factor. J. Biol. Chem., 2005, 280, 14586-14590.
19. Rosengren, K.J.; Lin, F.; Bathgate, R.A.; Tregear, G.W.; Daly, N.L.; Wade, J.D.; Craik, D.J. Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. J. Biol. Chem., 2006, 281, 5845-5851.
20. Rosengren, K.J.; Zhang, S.; Lin, F.; Daly, N.L.; Scott, D.J.; Hughes, R.A.; Bathgate, R.A.; Craik, D.J.; Wade, J.D. Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide. J. Biol. Chem., 2006, 281, 28287-28295.
21. Eigenbrot, C.; Randal, M.; Quan, C.; Burnier, J.; O'Connell, L.; Rinderknecht, E.; Kossiakoff, A. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. J. Mol. Biol., 1991, 221, 15-21.
22. Park, J.I.; Semyonov, J.; Yi, W.; Chang, C.L.; Hsu, S.Y. Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs. J. Biol. Chem., 2008, 283, 32099-32109.
23. McGowan, B.M.; Stanley, S.A.; Smith, K.L.; White, N.E.; Connolly, M.M.; Thompson, E.L.; Gardiner, J.V.; Murphy, K.G.; Ghatei, M.A.; Bloom, S.R. Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology, 2005, 146, 3295-3300.
24. Liu, C.; Chen, J.; Kuei, C.; Sutton, S.; Nepomuceno, D.; Bonaventure, P.; Lovenberg, T. W. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol., 2005, 67, 231-240.
25. McGowan, B.M.; Stanley, S.A.; Smith, K.L.; Minnion, J.S.; Donovan, J.; Thompson, E.L.; Patterson, M.; Connolly, M.M.; Abbott, C.R.; Small, C.J.; Gardiner, J.V.; Ghatei, M.A.; Bloom, S.R. Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul. Pept., 2006, 136, 72-77.
26. Hida, T.; Takahashi, E.; Shikata, K.; Hirohashi, T.; Sawai, T.; Seiki, T.; Tanaka, H.; Kawai, T.; Ito, O.; Arai, T.; Yokoi, A.; Hirakawa, T.; Ogura, H.; Nagasu, T.; Miyamoto, N.; Kuromitsu, J. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J. Recept. Signal. Transduct. Res., 2006, 26, 147-158.
27. Ma, S.; Olucha-Bordonau, F.E.; Hossain, M.A.; Lin, F.; Kuei, C.; Liu, C.; Wade, J.D.; Sutton, S.W.; Nunez, A.; Gundlach, A.L. Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn. Mem., 2009, 16, 730-742.
28. Liu, C.; Kuei, C.; Sutton, S.; Shelton, J.; Zhu, J.; Nepomuceno, D.; Hossain, M.A.; Wade, J.D.; Bathgate, R.A.; Bonaventure, P.; Lovenberg, T. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Ann. N. Y. Acad. Sci., 2009, 1160, 31-37.
29. Kuei, C.; Sutton, S.; Bonaventure, P.; Pudiak, C.; Shelton, J.; Zhu, J.; Nepomuceno, D.; Wu, J.; Chen, J.; Kamme, F.; Seierstad, M.; Hack, M.D.; Bathgate, R.A.; Hossain, M.A.; Wade, J.D.; Atack, J.; Lovenberg, T.W.; Liu, C. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. J. Biol. Chem., 2007, 282, 25425-25435.